...
机译:良性和恶性前列腺病变中频繁的14-3-3σ启动子甲基化
Under a licensing agreement between Oncomethylome Sciences, SA, and the Johns Hopkins University, Dr. Sidransky is entitled to a shareof royalty received by the University on sales of products described in this article. Dr. Sidransky owns Oncomethylome Sciences, SA, stock,which is subject to certain restrictions under University policy. Dr. Sidransky is a paid consultant to Oncomethylome Sciences, SA, and is a paidmember of the company’s Scientific Advisory Board. The term of this arrangement is being managed by the Johns Hopkins University in accordancewith its conflict of interest policies.1Department of Otolaryngology—Head and Neck Surgery, Head and Neck Cancer Research Division, Johns Hopkins University School ofMedicine, Baltimore, Maryland.Departments of 2Pathology, 3Genetics, and 4Urology, Portuguese Oncology Institute—Porto, Porto, Portugal.5Fernando Pessoa University School of Health Sciences, Porto, Portugal.;
14-3-3σ; prostate carcinoma (PCa); high-grade prostatic intraepithelial neoplasias (HGPIN);
机译:RASSF1A启动子甲基化经常在恶性前和非恶性微解剖的前列腺上皮组织中检测到。
机译:galectin在正常,良性和恶性前列腺上皮细胞中的差异表达:通过启动子甲基化使galectin-3在前列腺癌中的表达沉默
机译:甲基化型甲基化型甲基化型致羟基和恶性前列腺细胞的鉴定鉴定
机译:超声图像对恶性和良性前列腺病变的统计学区分
机译:区分乳腺良性和恶性炎症病变:T2加权和弥散加权MR图像的价值
机译:人体良性和恶性前列腺中维生素D 24-羟化酶/ CYP24A1基因启动子甲基化的甲基化
机译:差异维生素D 24-羟化酶/ CYP24A1Gene启动子甲基化在良性和恶性人前列腺内皮中